NOTE: This video is ONLY available to watch in selected countries and geographies
With a list of benefits including customisability, high radiopacity and shortened procedure times, the TRUFILL n-BCA liquid embolic system (Johnson & Johnson) should be considered a “critical tool” in the armamentarium of every neurointerventionist. That is according to Sudhakar Satti (Newark, USA), who recently discussed his experiences with the system in a video interview with NeuroNews.
In this interview, Satti also outlines the real-world advantages enabled by the TRUFILL n-BCA Procedural Set in a clinical setting, and provides an overview of his journey with the system over the past few years.
This video, available only to US audiences, is sponsored by Johnson & Johnson.
